Clinically, upregulation of CREB was found in various human cancer samples including prostate cancer, breast cancer, non-small-cell lung cancer and acute leukemia, whereas down-regulation of this gene manifested inhibition of some cancer cells [41]. This evidence concerns the gene CREB1 and breast cancer.